TP53 and Merkel cell skin cancer: Focusing on the overexpression of MDM4 in MCPyV-positive MCC cell lines, Park et al. used Lenalidomide, which is a selective MDM4 inhibitor, which when used alone exhibited only a modest increase in p53 levels in MCC cell lines.